About Contact Us Careers
Sign In

Multiple System Atrophy Market - Top Companies and Manufacturers

  • Report ID: 3440
  • Published Date: Aug 27, 2024
  • Report Format: PDF, PPT

Companies Dominating the Multiple System Atrophy (MSA) Landscape

    • Chelsea Therapeutics International, Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Biohaven Pharmaceuticals, Inc.
    • Sumitomo Dainippon Pharma Co., Ltd.
    • AstraZeneca plc
    • Theravance Biopharma, Inc.
    • Merck & Co.
    • Neuropore Therapies Inc
    • Newron Pharmaceuticals SpA
    • ProMIS Neurosciences Inc
    • Stealth BioTherapeutics Corp
Browse Key Market Insights with Data Illustration:

In the News

  • March 18, 2020- Biohaven Pharmaceutical’s myeloperoxidase (MPO) inhibitor, verdiperstat, received fast track designation from the United States Food and Drug Administration for treating multiple system atrophy or MSA. The drug is aimed at slowing the progression of the disease.


Author Credits:  Radhika Pawar


  • Report ID: 3440
  • Published Date: Aug 27, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of multiple system atrophy is assessed at USD 144.42 million.

Multiple System Atrophy (MSA) Market size was over USD 139.4 million in 2023 and is anticipated to reach USD 247.04 million by 2036, growing at around 4.5% CAGR during the forecast period i.e., between 2024-2036. The market growth is impelled by growing occurrence of multiple system atrophy across the world and increasing research and development activities to develop effective treatment for systemic atrophies.

Asia Pacific is set to account for largest revenue share by 2036, on the back of increasing number of cases of multiple system atrophy, especially in Japan, high patient pool and growing government initiatives to improve the infrastructure of healthcare in the region.

The major players in the market are Chelsea Therapeutics International, Ltd., Biohaven Pharmaceuticals, Inc., Sumitomo Dainippon Pharma Co., Ltd., AstraZeneca plc, and others.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample